Share Price and Basic Stock Data
Last Updated: December 12, 2025, 8:16 pm
| PEG Ratio | 1.66 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Grauer & Weil (India) Ltd, a player in the specialty chemicals sector, has shown a commendable trajectory in its revenue streams. For the fiscal year ending March 2025, the company reported sales of ₹1,134 Cr, a notable increase from ₹1,068 Cr in the previous year. This growth reflects a robust demand for its products, particularly in a market where specialty chemicals are becoming increasingly crucial for various industries. The quarterly performance also indicates fluctuations, with a peak revenue of ₹333 Cr in March 2024, suggesting seasonality in sales or project-based revenue recognition. However, the sales dipped to ₹250 Cr in September 2023, which raises questions about sustainability. As the industry is characterized by high competition, maintaining this growth momentum will be vital for long-term stability.
Profitability and Efficiency Metrics
The profitability metrics of Grauer & Weil reveal a mixed bag. The net profit for FY 2025 stood at ₹157 Cr, which translates to a net profit margin of approximately 13.86%. While this is an improvement from 13.68% in FY 2024, it still suggests that the margins are under pressure, especially when compared to industry leaders who often report margins exceeding 20%. Operating profit margins (OPM) recorded at 17% for FY 2025 also indicate that while the company is profitable, it may not be leveraging its operational efficiency to the fullest. The return on equity (ROE) of 17.6% is respectable, but in a sector that often sees higher returns, Grauer & Weil must focus on enhancing operational efficiencies to boost profitability further.
Balance Sheet Strength and Financial Ratios
Analyzing the balance sheet, Grauer & Weil appears to be in a solid position. With total borrowings at a mere ₹12 Cr against reserves of ₹952 Cr, the company enjoys a debt-to-equity ratio of just 0.01, showcasing a conservative approach to financing. This low leverage means the company is less vulnerable to interest rate fluctuations, which is a significant strength in the current economic climate. Furthermore, the interest coverage ratio (ICR) of 85.67x suggests that the company can easily meet its interest obligations, indicating strong liquidity. However, the price-to-book (P/B) ratio of 3.96x may seem stretched when compared to industry norms, potentially signaling that the stock is perceived as overvalued by some investors. Balancing growth with prudent financial management will be essential for sustaining investor confidence.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Grauer & Weil illustrates a strong promoter stake of 69.03%, indicating significant insider confidence in the company’s future. However, foreign institutional investors (FIIs) hold only 0.68%, which raises concerns about international market sentiment towards the stock. The presence of domestic institutional investors (DIIs) is negligible at 0.03%, suggesting limited institutional interest. This could imply that while promoters are committed, the broader investment community may be cautious. The total number of shareholders stands at 55,578, indicating a reasonably diversified retail base, but the lack of institutional backing could impact the stock’s liquidity and price stability. Attracting more institutional investment may be crucial for enhancing market perception.
Outlook, Risks, and Final Insight
While Grauer & Weil demonstrates several strengths, including strong balance sheet fundamentals and a committed promoter base, risks remain. The fluctuating revenue trends could signal potential volatility in future earnings, which may deter risk-averse investors. Additionally, the low institutional interest may affect liquidity, leading to price swings. On the operational front, sustaining profitability in a competitive landscape will require strategic initiatives, possibly including innovation and cost management strategies. For investors, the stock presents an intriguing opportunity balanced by risks. It’s essential to weigh the company’s financial health against market dynamics carefully. The outlook seems cautiously optimistic, but vigilance regarding performance consistency and market sentiment will be key for potential investors.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| HP Adhesives Ltd | 394 Cr. | 42.9 | 83.5/41.2 | 24.5 | 20.5 | 0.93 % | 13.6 % | 9.82 % | 2.00 |
| Haryana Leather Chemicals Ltd | 31.9 Cr. | 64.9 | 99.5/56.0 | 15.2 | 89.6 | 1.54 % | 8.02 % | 5.45 % | 10.0 |
| Hardcastle & Waud Mfg Co Ltd | 45.6 Cr. | 670 | 960/600 | 21.0 | 697 | 0.00 % | 6.31 % | 2.91 % | 10.0 |
| Grauer & Weil (India) Ltd | 3,470 Cr. | 76.5 | 111/74.5 | 23.0 | 22.0 | 0.65 % | 23.3 % | 17.6 % | 1.00 |
| DMCC Speciality Chemicals Ltd | 651 Cr. | 261 | 453/241 | 23.4 | 93.8 | 0.96 % | 14.1 % | 9.97 % | 10.0 |
| Industry Average | 12,832.80 Cr | 725.78 | 65.85 | 183.02 | 0.44% | 12.99% | 25.41% | 6.41 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 199 | 205 | 251 | 327 | 200 | 250 | 285 | 333 | 264 | 255 | 275 | 340 | 253 |
| Expenses | 159 | 166 | 204 | 297 | 152 | 202 | 230 | 294 | 200 | 212 | 222 | 311 | 201 |
| Operating Profit | 40 | 39 | 47 | 30 | 48 | 49 | 55 | 39 | 64 | 43 | 52 | 30 | 53 |
| OPM % | 20% | 19% | 19% | 9% | 24% | 20% | 19% | 12% | 24% | 17% | 19% | 9% | 21% |
| Other Income | 4 | 4 | 5 | 4 | 6 | 7 | 9 | 8 | 8 | 14 | 12 | 12 | 13 |
| Interest | 0 | -0 | 1 | 1 | 0 | 0 | 0 | 3 | 0 | 0 | 1 | 2 | 1 |
| Depreciation | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 6 | 6 | 6 | 6 |
| Profit before tax | 39 | 38 | 47 | 29 | 48 | 51 | 58 | 39 | 67 | 51 | 58 | 34 | 58 |
| Tax % | 25% | 26% | 26% | 25% | 23% | 26% | 26% | 26% | 24% | 26% | 26% | 25% | 25% |
| Net Profit | 29 | 28 | 34 | 22 | 37 | 37 | 43 | 29 | 51 | 38 | 43 | 26 | 44 |
| EPS in Rs | 0.64 | 0.62 | 0.76 | 0.48 | 0.81 | 0.83 | 0.94 | 0.64 | 1.12 | 0.83 | 0.95 | 0.57 | 0.96 |
Last Updated: August 19, 2025, 2:25 pm
Below is a detailed analysis of the quarterly data for Grauer & Weil (India) Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 253.00 Cr.. The value appears to be declining and may need further review. It has decreased from 340.00 Cr. (Mar 2025) to 253.00 Cr., marking a decrease of 87.00 Cr..
- For Expenses, as of Jun 2025, the value is 201.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 311.00 Cr. (Mar 2025) to 201.00 Cr., marking a decrease of 110.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 53.00 Cr.. The value appears strong and on an upward trend. It has increased from 30.00 Cr. (Mar 2025) to 53.00 Cr., marking an increase of 23.00 Cr..
- For OPM %, as of Jun 2025, the value is 21.00%. The value appears strong and on an upward trend. It has increased from 9.00% (Mar 2025) to 21.00%, marking an increase of 12.00%.
- For Other Income, as of Jun 2025, the value is 13.00 Cr.. The value appears strong and on an upward trend. It has increased from 12.00 Cr. (Mar 2025) to 13.00 Cr., marking an increase of 1.00 Cr..
- For Interest, as of Jun 2025, the value is 1.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2.00 Cr. (Mar 2025) to 1.00 Cr., marking a decrease of 1.00 Cr..
- For Depreciation, as of Jun 2025, the value is 6.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 6.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 58.00 Cr.. The value appears strong and on an upward trend. It has increased from 34.00 Cr. (Mar 2025) to 58.00 Cr., marking an increase of 24.00 Cr..
- For Tax %, as of Jun 2025, the value is 25.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 25.00%.
- For Net Profit, as of Jun 2025, the value is 44.00 Cr.. The value appears strong and on an upward trend. It has increased from 26.00 Cr. (Mar 2025) to 44.00 Cr., marking an increase of 18.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 0.96. The value appears strong and on an upward trend. It has increased from 0.57 (Mar 2025) to 0.96, marking an increase of 0.39.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 3:37 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 380 | 409 | 413 | 432 | 497 | 600 | 618 | 605 | 768 | 981 | 1,068 | 1,134 | 1,159 |
| Expenses | 319 | 333 | 335 | 346 | 400 | 494 | 521 | 505 | 655 | 825 | 877 | 944 | 982 |
| Operating Profit | 61 | 76 | 78 | 86 | 98 | 106 | 97 | 101 | 114 | 156 | 191 | 189 | 178 |
| OPM % | 16% | 19% | 19% | 20% | 20% | 18% | 16% | 17% | 15% | 16% | 18% | 17% | 15% |
| Other Income | 3 | 1 | 2 | 4 | 10 | 5 | 20 | 15 | 16 | 18 | 31 | 46 | 48 |
| Interest | 17 | 14 | 10 | 3 | 3 | 2 | 3 | 3 | 3 | 3 | 5 | 4 | 3 |
| Depreciation | 12 | 16 | 14 | 14 | 15 | 15 | 19 | 18 | 20 | 20 | 21 | 22 | 24 |
| Profit before tax | 35 | 46 | 56 | 73 | 91 | 94 | 95 | 94 | 107 | 152 | 196 | 210 | 199 |
| Tax % | 14% | 28% | 24% | 26% | 30% | 32% | 21% | 27% | 26% | 26% | 25% | 25% | |
| Net Profit | 30 | 33 | 42 | 54 | 64 | 64 | 76 | 69 | 79 | 113 | 146 | 157 | 151 |
| EPS in Rs | 0.67 | 0.74 | 0.93 | 1.20 | 1.41 | 1.41 | 1.67 | 1.52 | 1.74 | 2.49 | 3.23 | 3.47 | 3.33 |
| Dividend Payout % | 12% | 15% | 15% | 17% | 21% | 21% | 15% | 16% | 19% | 16% | 8% | 14% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 10.00% | 27.27% | 28.57% | 18.52% | 0.00% | 18.75% | -9.21% | 14.49% | 43.04% | 29.20% | 7.53% |
| Change in YoY Net Profit Growth (%) | 0.00% | 17.27% | 1.30% | -10.05% | -18.52% | 18.75% | -27.96% | 23.70% | 28.55% | -13.83% | -21.67% |
Grauer & Weil (India) Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 13% |
| 3 Years: | 14% |
| TTM: | -1% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 17% |
| 3 Years: | 26% |
| TTM: | -6% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 28% |
| 5 Years: | 35% |
| 3 Years: | 40% |
| 1 Year: | -11% |
| Return on Equity | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 17% |
| 3 Years: | 18% |
| Last Year: | 18% |
Last Updated: September 5, 2025, 3:40 pm
Balance Sheet
Last Updated: December 4, 2025, 2:59 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 23 | 23 | 23 | 23 | 23 | 23 | 23 | 23 | 23 | 23 | 23 | 45 | 45 |
| Reserves | 171 | 194 | 228 | 278 | 331 | 379 | 422 | 491 | 560 | 657 | 783 | 894 | 952 |
| Borrowings | 97 | 68 | 27 | 20 | 7 | 21 | 23 | 22 | 25 | 24 | 27 | 12 | 12 |
| Other Liabilities | 133 | 125 | 119 | 133 | 146 | 159 | 174 | 214 | 217 | 251 | 292 | 334 | 319 |
| Total Liabilities | 423 | 410 | 397 | 454 | 507 | 581 | 642 | 750 | 824 | 954 | 1,124 | 1,286 | 1,328 |
| Fixed Assets | 225 | 216 | 210 | 212 | 206 | 231 | 241 | 238 | 247 | 244 | 243 | 254 | 269 |
| CWIP | 1 | 0 | 0 | 0 | 0 | 3 | 1 | 4 | 1 | 3 | 14 | 27 | 20 |
| Investments | 3 | 2 | 1 | 1 | 3 | 1 | 0 | 0 | 1 | 17 | 49 | 71 | 407 |
| Other Assets | 194 | 192 | 186 | 241 | 297 | 346 | 399 | 508 | 576 | 690 | 817 | 934 | 633 |
| Total Assets | 423 | 410 | 397 | 454 | 507 | 581 | 642 | 750 | 824 | 954 | 1,124 | 1,286 | 1,328 |
Below is a detailed analysis of the balance sheet data for Grauer & Weil (India) Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 45.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 45.00 Cr..
- For Reserves, as of Sep 2025, the value is 952.00 Cr.. The value appears strong and on an upward trend. It has increased from 894.00 Cr. (Mar 2025) to 952.00 Cr., marking an increase of 58.00 Cr..
- For Borrowings, as of Sep 2025, the value is 12.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2025) which recorded 12.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 319.00 Cr.. The value appears to be improving (decreasing). It has decreased from 334.00 Cr. (Mar 2025) to 319.00 Cr., marking a decrease of 15.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 1,328.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,286.00 Cr. (Mar 2025) to 1,328.00 Cr., marking an increase of 42.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 269.00 Cr.. The value appears strong and on an upward trend. It has increased from 254.00 Cr. (Mar 2025) to 269.00 Cr., marking an increase of 15.00 Cr..
- For CWIP, as of Sep 2025, the value is 20.00 Cr.. The value appears to be declining and may need further review. It has decreased from 27.00 Cr. (Mar 2025) to 20.00 Cr., marking a decrease of 7.00 Cr..
- For Investments, as of Sep 2025, the value is 407.00 Cr.. The value appears strong and on an upward trend. It has increased from 71.00 Cr. (Mar 2025) to 407.00 Cr., marking an increase of 336.00 Cr..
- For Other Assets, as of Sep 2025, the value is 633.00 Cr.. The value appears to be declining and may need further review. It has decreased from 934.00 Cr. (Mar 2025) to 633.00 Cr., marking a decrease of 301.00 Cr..
- For Total Assets, as of Sep 2025, the value is 1,328.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,286.00 Cr. (Mar 2025) to 1,328.00 Cr., marking an increase of 42.00 Cr..
Notably, the Reserves (952.00 Cr.) exceed the Borrowings (12.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -36.00 | 8.00 | 51.00 | 66.00 | 91.00 | 85.00 | 74.00 | 79.00 | 89.00 | 132.00 | 164.00 | 177.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 89 | 80 | 70 | 63 | 65 | 68 | 67 | 77 | 62 | 68 | 63 | 64 |
| Inventory Days | 109 | 120 | 115 | 118 | 100 | 106 | 126 | 108 | 121 | 83 | 90 | 98 |
| Days Payable | 79 | 67 | 68 | 82 | 81 | 68 | 95 | 110 | 91 | 77 | 86 | 90 |
| Cash Conversion Cycle | 119 | 133 | 117 | 99 | 83 | 106 | 99 | 75 | 92 | 75 | 68 | 72 |
| Working Capital Days | 17 | 26 | 50 | 38 | 49 | 56 | 57 | 36 | 49 | 43 | 34 | 32 |
| ROCE % | 18% | 21% | 24% | 25% | 27% | 26% | 20% | 19% | 19% | 24% | 26% | 23% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 3.47 | 6.45 | 4.98 | 3.47 | 3.04 |
| Diluted EPS (Rs.) | 3.47 | 6.45 | 4.98 | 3.47 | 3.04 |
| Cash EPS (Rs.) | 3.96 | 7.38 | 5.86 | 4.34 | 3.85 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 20.72 | 35.52 | 29.96 | 25.69 | 22.67 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 20.72 | 35.52 | 29.96 | 25.69 | 22.67 |
| Revenue From Operations / Share (Rs.) | 25.00 | 47.15 | 43.31 | 33.89 | 26.72 |
| PBDIT / Share (Rs.) | 5.18 | 9.77 | 7.69 | 5.58 | 5.07 |
| PBIT / Share (Rs.) | 4.68 | 8.84 | 6.82 | 4.71 | 4.26 |
| PBT / Share (Rs.) | 4.62 | 8.66 | 6.70 | 4.71 | 4.16 |
| Net Profit / Share (Rs.) | 3.47 | 6.45 | 4.98 | 3.47 | 3.04 |
| NP After MI And SOA / Share (Rs.) | 3.47 | 6.45 | 4.98 | 3.47 | 3.04 |
| PBDIT Margin (%) | 20.70 | 20.71 | 17.75 | 16.45 | 18.97 |
| PBIT Margin (%) | 18.73 | 18.74 | 15.74 | 13.90 | 15.93 |
| PBT Margin (%) | 18.48 | 18.35 | 15.47 | 13.89 | 15.57 |
| Net Profit Margin (%) | 13.86 | 13.68 | 11.50 | 10.24 | 11.37 |
| NP After MI And SOA Margin (%) | 13.86 | 13.68 | 11.50 | 10.25 | 11.35 |
| Return on Networth / Equity (%) | 16.73 | 18.16 | 16.62 | 13.52 | 13.38 |
| Return on Capital Employeed (%) | 21.47 | 23.24 | 21.11 | 16.88 | 16.97 |
| Return On Assets (%) | 12.22 | 12.99 | 11.83 | 9.55 | 9.17 |
| Total Debt / Equity (X) | 0.01 | 0.02 | 0.02 | 0.03 | 0.03 |
| Asset Turnover Ratio (%) | 0.94 | 1.03 | 1.10 | 0.97 | 0.86 |
| Current Ratio (X) | 3.15 | 3.16 | 2.87 | 2.89 | 2.75 |
| Quick Ratio (X) | 2.63 | 2.64 | 2.30 | 2.14 | 2.24 |
| Inventory Turnover Ratio (X) | 7.71 | 4.22 | 4.11 | 3.81 | 3.03 |
| Dividend Payout Ratio (NP) (%) | 14.42 | 22.47 | 13.04 | 14.38 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 12.62 | 19.63 | 11.09 | 11.51 | 0.00 |
| Earning Retention Ratio (%) | 85.58 | 77.53 | 86.96 | 85.62 | 0.00 |
| Cash Earning Retention Ratio (%) | 87.38 | 80.37 | 88.91 | 88.49 | 0.00 |
| Interest Coverage Ratio (X) | 85.67 | 53.77 | 93.63 | 50.36 | 53.33 |
| Interest Coverage Ratio (Post Tax) (X) | 58.37 | 36.51 | 62.04 | 31.37 | 32.99 |
| Enterprise Value (Cr.) | 3259.26 | 3602.56 | 1964.44 | 1088.88 | 653.83 |
| EV / Net Operating Revenue (X) | 2.87 | 3.37 | 2.00 | 1.42 | 1.08 |
| EV / EBITDA (X) | 13.88 | 16.27 | 11.27 | 8.61 | 5.69 |
| MarketCap / Net Operating Revenue (X) | 3.28 | 3.74 | 2.27 | 1.73 | 1.47 |
| Retention Ratios (%) | 85.57 | 77.52 | 86.95 | 85.61 | 0.00 |
| Price / BV (X) | 3.96 | 4.97 | 3.29 | 2.28 | 1.73 |
| Price / Net Operating Revenue (X) | 3.28 | 3.74 | 2.27 | 1.73 | 1.47 |
| EarningsYield | 0.04 | 0.03 | 0.05 | 0.05 | 0.07 |
After reviewing the key financial ratios for Grauer & Weil (India) Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 3.47. This value is below the healthy minimum of 5. It has decreased from 6.45 (Mar 24) to 3.47, marking a decrease of 2.98.
- For Diluted EPS (Rs.), as of Mar 25, the value is 3.47. This value is below the healthy minimum of 5. It has decreased from 6.45 (Mar 24) to 3.47, marking a decrease of 2.98.
- For Cash EPS (Rs.), as of Mar 25, the value is 3.96. This value is within the healthy range. It has decreased from 7.38 (Mar 24) to 3.96, marking a decrease of 3.42.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 20.72. It has decreased from 35.52 (Mar 24) to 20.72, marking a decrease of 14.80.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 20.72. It has decreased from 35.52 (Mar 24) to 20.72, marking a decrease of 14.80.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 25.00. It has decreased from 47.15 (Mar 24) to 25.00, marking a decrease of 22.15.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 5.18. This value is within the healthy range. It has decreased from 9.77 (Mar 24) to 5.18, marking a decrease of 4.59.
- For PBIT / Share (Rs.), as of Mar 25, the value is 4.68. This value is within the healthy range. It has decreased from 8.84 (Mar 24) to 4.68, marking a decrease of 4.16.
- For PBT / Share (Rs.), as of Mar 25, the value is 4.62. This value is within the healthy range. It has decreased from 8.66 (Mar 24) to 4.62, marking a decrease of 4.04.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 3.47. This value is within the healthy range. It has decreased from 6.45 (Mar 24) to 3.47, marking a decrease of 2.98.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 3.47. This value is within the healthy range. It has decreased from 6.45 (Mar 24) to 3.47, marking a decrease of 2.98.
- For PBDIT Margin (%), as of Mar 25, the value is 20.70. This value is within the healthy range. It has decreased from 20.71 (Mar 24) to 20.70, marking a decrease of 0.01.
- For PBIT Margin (%), as of Mar 25, the value is 18.73. This value is within the healthy range. It has decreased from 18.74 (Mar 24) to 18.73, marking a decrease of 0.01.
- For PBT Margin (%), as of Mar 25, the value is 18.48. This value is within the healthy range. It has increased from 18.35 (Mar 24) to 18.48, marking an increase of 0.13.
- For Net Profit Margin (%), as of Mar 25, the value is 13.86. This value exceeds the healthy maximum of 10. It has increased from 13.68 (Mar 24) to 13.86, marking an increase of 0.18.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 13.86. This value is within the healthy range. It has increased from 13.68 (Mar 24) to 13.86, marking an increase of 0.18.
- For Return on Networth / Equity (%), as of Mar 25, the value is 16.73. This value is within the healthy range. It has decreased from 18.16 (Mar 24) to 16.73, marking a decrease of 1.43.
- For Return on Capital Employeed (%), as of Mar 25, the value is 21.47. This value is within the healthy range. It has decreased from 23.24 (Mar 24) to 21.47, marking a decrease of 1.77.
- For Return On Assets (%), as of Mar 25, the value is 12.22. This value is within the healthy range. It has decreased from 12.99 (Mar 24) to 12.22, marking a decrease of 0.77.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.01. This value is within the healthy range. It has decreased from 0.02 (Mar 24) to 0.01, marking a decrease of 0.01.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.94. It has decreased from 1.03 (Mar 24) to 0.94, marking a decrease of 0.09.
- For Current Ratio (X), as of Mar 25, the value is 3.15. This value exceeds the healthy maximum of 3. It has decreased from 3.16 (Mar 24) to 3.15, marking a decrease of 0.01.
- For Quick Ratio (X), as of Mar 25, the value is 2.63. This value exceeds the healthy maximum of 2. It has decreased from 2.64 (Mar 24) to 2.63, marking a decrease of 0.01.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 7.71. This value is within the healthy range. It has increased from 4.22 (Mar 24) to 7.71, marking an increase of 3.49.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 14.42. This value is below the healthy minimum of 20. It has decreased from 22.47 (Mar 24) to 14.42, marking a decrease of 8.05.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 12.62. This value is below the healthy minimum of 20. It has decreased from 19.63 (Mar 24) to 12.62, marking a decrease of 7.01.
- For Earning Retention Ratio (%), as of Mar 25, the value is 85.58. This value exceeds the healthy maximum of 70. It has increased from 77.53 (Mar 24) to 85.58, marking an increase of 8.05.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 87.38. This value exceeds the healthy maximum of 70. It has increased from 80.37 (Mar 24) to 87.38, marking an increase of 7.01.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 85.67. This value is within the healthy range. It has increased from 53.77 (Mar 24) to 85.67, marking an increase of 31.90.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 58.37. This value is within the healthy range. It has increased from 36.51 (Mar 24) to 58.37, marking an increase of 21.86.
- For Enterprise Value (Cr.), as of Mar 25, the value is 3,259.26. It has decreased from 3,602.56 (Mar 24) to 3,259.26, marking a decrease of 343.30.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.87. This value is within the healthy range. It has decreased from 3.37 (Mar 24) to 2.87, marking a decrease of 0.50.
- For EV / EBITDA (X), as of Mar 25, the value is 13.88. This value is within the healthy range. It has decreased from 16.27 (Mar 24) to 13.88, marking a decrease of 2.39.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 3.28. This value exceeds the healthy maximum of 3. It has decreased from 3.74 (Mar 24) to 3.28, marking a decrease of 0.46.
- For Retention Ratios (%), as of Mar 25, the value is 85.57. This value exceeds the healthy maximum of 70. It has increased from 77.52 (Mar 24) to 85.57, marking an increase of 8.05.
- For Price / BV (X), as of Mar 25, the value is 3.96. This value exceeds the healthy maximum of 3. It has decreased from 4.97 (Mar 24) to 3.96, marking a decrease of 1.01.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 3.28. This value exceeds the healthy maximum of 3. It has decreased from 3.74 (Mar 24) to 3.28, marking a decrease of 0.46.
- For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has increased from 0.03 (Mar 24) to 0.04, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Grauer & Weil (India) Ltd:
- Net Profit Margin: 13.86%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 21.47% (Industry Average ROCE: 12.99%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 16.73% (Industry Average ROE: 25.41%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 58.37
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.63
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 23 (Industry average Stock P/E: 65.85)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.01
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 13.86%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Speciality - Others | Growel Corporate, Mumbai Maharashtra 400101 | secretarial@growel.com http://www.growel.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Umeshkumar More | Chairman |
| Mr. Nirajkumar More | Managing Director |
| Mr. Rohitkumar More | Whole Time Director |
| Mr. Yogesh Samat | Whole Time Director |
| Dr. Prerna Goradia | Independent Director |
| Mr. Ayush Agarwala | Independent Director |
| Mr. Ashok Kumar Kanodia | Independent Director |
| Mr. Anil Gadodia | Independent Director |
FAQ
What is the intrinsic value of Grauer & Weil (India) Ltd?
Grauer & Weil (India) Ltd's intrinsic value (as of 14 December 2025) is 71.71 which is 6.26% lower the current market price of 76.50, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 3,470 Cr. market cap, FY2025-2026 high/low of 111/74.5, reserves of ₹952 Cr, and liabilities of 1,328 Cr.
What is the Market Cap of Grauer & Weil (India) Ltd?
The Market Cap of Grauer & Weil (India) Ltd is 3,470 Cr..
What is the current Stock Price of Grauer & Weil (India) Ltd as on 14 December 2025?
The current stock price of Grauer & Weil (India) Ltd as on 14 December 2025 is 76.5.
What is the High / Low of Grauer & Weil (India) Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Grauer & Weil (India) Ltd stocks is 111/74.5.
What is the Stock P/E of Grauer & Weil (India) Ltd?
The Stock P/E of Grauer & Weil (India) Ltd is 23.0.
What is the Book Value of Grauer & Weil (India) Ltd?
The Book Value of Grauer & Weil (India) Ltd is 22.0.
What is the Dividend Yield of Grauer & Weil (India) Ltd?
The Dividend Yield of Grauer & Weil (India) Ltd is 0.65 %.
What is the ROCE of Grauer & Weil (India) Ltd?
The ROCE of Grauer & Weil (India) Ltd is 23.3 %.
What is the ROE of Grauer & Weil (India) Ltd?
The ROE of Grauer & Weil (India) Ltd is 17.6 %.
What is the Face Value of Grauer & Weil (India) Ltd?
The Face Value of Grauer & Weil (India) Ltd is 1.00.